On July 9, 2025, Vor Biopharma Inc. appointed Sandesh Mahatme as its Chief Financial Officer, with a salary of $480,000 and a one-time signing bonus of $274,000; he will also receive 13.9 million restricted stock units. This filing is significant as it marks a key management change.